• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

The impact of activated PI3K signal on pancreatic cancer

Research Project

  • PDF
Project/Area Number 22590756
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionThe University of Tokyo

Principal Investigator

SASAHIRA Naoki  東京大学, 医学部附属病院, 助教 (30401102)

Co-Investigator(Kenkyū-buntansha) TADA Minoru  東京大学, 医学部附属病院, 講師 (80302719)
IJICHI Hideaki  東京大学, 医学部附属病院, 助教 (70463841)
ASAOKA Yoshinari  東京大学, 医学部附属病院, 助教 (90431858)
Co-Investigator(Renkei-kenkyūsha) IKENOUE Tsuneo  東京大学, 医科学研究所, 准教授 (80396712)
Project Period (FY) 2010 – 2012
Keywords膵癌 / マウスモデル / 薬剤耐性 / 遺伝子異常
Research Abstract

We generated pancreatic cancer mouse model by inducing pancreas-specific expression of activated Kras and deletion of Pten. All the mice died from pancreas tumor in six weeks. We analyzed the effect of mTOR inhibitor, rapamycin, on pancreatic cancer cell lines with PTEN deletion or AKT2 amplification. Rapamycin had no anti-tumor effect using as a single agent or combination with gemcitabine. We discovered that low glucose medium predisposed these cells to apoptosis and rapamycin prevented this phenomenon. The result suggested that, under some conditions, mTOR inhibition could not exert anti-tumor effect even on PTEN-PI3K-AKT activated cancer.交付決定額(

  • Research Products

    (12 results)

All 2012 2011 2010

All Journal Article (10 results) (of which Peer Reviewed: 9 results) Presentation (2 results)

  • [Journal Article] Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression.2012

    • Author(s)
      Mohri D, Asaoka Y, Ijichi H, Miyabayashi K, Kudo Y, Seto M, Ohta M, Tada M, Tanaka Y, Ikenoue T, Tateishi K, IsayamaH, Kanai F, Fukushima N, Tada M, Kawabe T, Omata M, Koike K.J
    • Journal Title

      Gastroenterol

      Volume: 47(2) Pages: 203-13

    • DOI

      doi:10.1007/s00535-011-0482-y.

  • [Journal Article] Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1.2012

    • Author(s)
      Nakai Y, Isayama H, Ijichi H, Sasaki T, Kogure H, Yagioka H, Miyabayashi K, Mizuno S, Yamamoto K, Mouri D, Kawakubo K, Yamamoto N, Hirano K, Sasahira N, Tateishi K, Tada M, Koike K.
    • Journal Title

      Cancer Sci

      Volume: 103(8) Pages: 1489-92

    • DOI

      doi:10.1111/j.1349-7006.2012.02311.x.

    • Peer Reviewed
  • [Journal Article] Comorbidity, not age, is prognostic inpatients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy.2011

    • Author(s)
      Nakai Y, Isayama H, Sasaki T, Sasahira N, Tsujino T, Kogure H, Yagioka H, Yashima Y, Togawa O, Arizumi T, Matsubara S, Hirano K, Tada M, Omata M, Koike K.
    • Journal Title

      Crit Rev Oncol Hematol

      Volume: 78(3) Pages: 252-9

    • DOI

      doi:10.1016/j.critrevonc.2010.05.007.

    • Peer Reviewed
  • [Journal Article] Incidence of extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas.2011

    • Author(s)
      Kawakubo K, Tada M, Isayama H, Sasahira N, Nakai Y, Yamamoto K, Kogure H, Sasaki T, Hirano K, Ijichi H, Tateishi K, Yoshida H, Koike K.
    • Journal Title

      Gut

      Volume: 60(9) Pages: 1249-53

    • DOI

      doi:10.1136/gut.2010.227306.

    • Peer Reviewed
  • [Journal Article] Specific increase in serum autotaxin activity in patients with pancreatic cancer2011

    • Author(s)
      Nakai Y, Ikeda H, Nakamura K, Kume Y, Fujishiro M, Sasahira N, Hirano K, Isayama H, Tada M, Kawabe T, Komatsu Y, Omata M, Aoki J, Koike K, Yatomi Y.
    • Journal Title

      Clin Biochem

      Volume: 44(8-9) Pages: 576-81

    • DOI

      doi:10.1016/j.clinbiochem.2011.03.128.

    • Peer Reviewed
  • [Journal Article] Gemcitabine and oxaliplatin combination chemotherapy for patients with refractory pancreatic cancer.2011

    • Author(s)
      Isayama H, Nakai Y, Yamamoto K, Sasaki T, Mizuno S, Yagioka H, Yashima Y, Kawakubo K, Kogure H, Arizumi T,Togawa O, Ito Y, Matsubara S, Yamamoto N, Sasahira N, Hirano K, Tsujino T, Tada M, Omata M, Koike K.
    • Journal Title

      Oncology

      Volume: 80(1-2) Pages: 97-101

    • DOI

      doi:10.1159/000328767.

    • Peer Reviewed
  • [Journal Article] Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.2011

    • Author(s)
      Ijichi H, Chytil A, Gorska AE, Aakre ME, Bierie B, Tada M, Mohri D, Miyabayashi K, Asaoka Y, Maeda S, Ikenoue T, Tateishi K, Wright CV, Koike K, Omata M, Moses HL.J Clin
    • Journal Title

      Invest

      Volume: 121(10) Pages: 4106-17

    • DOI

      doi:10.1172/JCI42754. Epub 2011 Sep 19.

    • Peer Reviewed
  • [Journal Article] Impact of S-1 in patients withgemcitabine-refractory pancreatic cancerin Japan2010

    • Author(s)
      Nakai Y, Isayama H, Sasaki T,Sasahira N, Kogure H, Hirano K, Tsujino T,Ijichi H, Tateishi K, Tada M, Omata M,Koike K.
    • Journal Title

      Jpn J Clin Oncol

      Volume: 40(8) Pages: 774-80

    • DOI

      doi:10.1093/jjco/hyq059.

    • Peer Reviewed
  • [Journal Article] Impact of S-1 on the survival of patientswith advanced pancreatic cancer2010

    • Author(s)
      Nakai Y,Isayama H, Sasaki T, Sasahira N, Ito Y,Kogure H, Togawa O, Matsubara S,Arizumi T, Yagioka H, Yashima Y,Kawakubo K, Mizuno S, Yamamoto K,Hirano K, Tsujino T, Ijichi H, Tateishi K,Toda N, Tada M, Omata M, Koike K.
    • Journal Title

      Pancreas

      Volume: 39(7) Pages: 989-93

    • DOI

      doi:10.1097/MPA.0b013e3181d91936.

    • Peer Reviewed
  • [Journal Article] A genetic polymorphism of CYP2C19 is associated with susceptibility to biliarytract cancer2010

    • Author(s)
      Isomura Y, Yamaji Y, OhtaM, Seto M, Asaoka Y, Tanaka Y, Sasaki T,Nakai Y, Sasahira N, Isayama H, Tada M,Yoshida H, Kawabe T, Omata M, Koike K.
    • Journal Title

      J Gastroenterol

      Volume: 45(10) Pages: 1045-52

    • DOI

      doi:10.1007/s00535-010-0246-0.

    • Peer Reviewed
  • [Presentation] Eose extracorporeal shockwave lithotripsy combined with endotherapy really improve the natural course of chronic pancreatitis2011

    • Author(s)
      Sasahira N.
    • Organizer
      Digestive Disease Week (DDW)
    • Place of Presentation
      Chicago, IL, USA
    • Year and Date
      20110507-0510
  • [Presentation] Fully covered self-expandable metal stent (FCSEMS) for refractory pancreatic duct stricture associated with chronic pancreatitis.2010

    • Author(s)
      Sasahira N.
    • Organizer
      Asian Pacific Digestive Week 2010
    • Place of Presentation
      Kuala Lumpur, Malaysia
    • Year and Date
      20100919-0922

URL: 

Published: 2014-08-29   Modified: 2015-10-06  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi